NASDAQ · Biotechnology

SGMT (SGMT) Stock

$8.74 +1.16% NASDAQ: SGMT Healthcare

Valuation

MetricValue
Price$8.74
Market Cap$284.76M
P/E Ratio-4.14
P/B Ratio1.92
P/S Ratio0.00
EPS (TTM)$-1.58
52-Week High$11.41
52-Week Low$4.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-45.95%
ROA-43.97%
ROCE-51.35%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio23.20

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$2.0M$0$0
Operating Profit$-24.0M$-31.0M$-31.0M$-54.0M$-57.0M
Net Profit$-24.0M$-30.0M$-28.0M$-46.0M$-51.0M
EPS$-1.10$-1.38$-1.53$-1.45$-1.58
Op Margin——-1537.0%——

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$59.0M$33.0M$97.0M$160.0M$116.0M
Total Liabilities$217.0M$220.0M$6.0M$4.0M$5.0M
Cash$57.0M$0$75.0M$76.0M$35.0M
Borrowings$0$0$0$0$0

Latest News

Sagimet Biosciences (SGMT) Attracts Attention After Russel Indexes Inclusion Insider Monkey · Jul 15, 2026 Sagimet Biosciences Added to Russell Indexes MT Newswires · Jun 29, 2026 Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes GlobeNewswire · Jun 29, 2026 Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jun 23, 2026 Here's Why Sagimet Biosciences Inc. (SGMT) Could be Great Choice for a Bottom Fisher Zacks · Jun 4, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-22.0M$-24.0M$-24.0M$-42.0M$-46.0M
Investing Cash Flow$0$-32.0M$13.0M$-62.0M$5.0M
Financing Cash Flow$-1.0M$0$-4.0M$-1.0M$0
Net Cash Flow$-12.0M$-57.0M$75.0M$1.0M$-41.0M
Free Cash Flow$-22.0M$-24.0M$-24.0M$-42.0M$-46.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-18.46%
Quick Ratio20.34
Interest Coverage—
Return 1Y-26.90%
Return 3Y-56.35%
Return 5Y—

Ownership

Insiders Held3.50%
Institutions Held22.69%
Institutions Float Held23.51%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC1,098,9192026-03-31
Woodline Partners LP1,000,9432026-03-31
Marshall Wace LLP966,2532026-03-31
Baker Bros. Advisors, LP952,9962026-03-31
Affinity Asset Advisors, Llc868,0202026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHV $6.66 +2.94% -4.63 $683.71M 0.00%
ARCT $6.26 +0.64% -2.93 $177.93M 0.00%
ASMB $26.68 +0.87% -51.53 $424.02M 0.00%
AVIR $4.75 +1.06% -2.13 $380.13M 0.00%
FHTXFoghorn Therapeutics Inc. $5.20 +7.22% -4.15 $305.31M 0.00%

About SGMT

SGMT is led by CEO David A. Happel, employs 14 people, headquartered in US, publicly traded since 2023.

SGMT stock trades at $8.74 with a market capitalization of $284.76M. The stock is valued at a price-to-earnings (P/E) ratio of -4.14, price-to-book of 1.92, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $4.50 and $11.41, and currently trades 23.4% below its 52-week high.

On profitability, SGMT generates a return on equity (ROE) of -45.95%, return on capital employed of -51.35%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides